Suppr超能文献

绘制抑制蛋白-受体界面图谱。负责抑制蛋白受体特异性的结构元件。

Mapping the arrestin-receptor interface. Structural elements responsible for receptor specificity of arrestin proteins.

作者信息

Vishnivetskiy Sergey A, Hosey M Marlene, Benovic Jeffrey L, Gurevich Vsevolod V

机构信息

Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

出版信息

J Biol Chem. 2004 Jan 9;279(2):1262-8. doi: 10.1074/jbc.M308834200. Epub 2003 Oct 6.

Abstract

Arrestins selectively bind to phosphorylated activated forms of their cognate G protein-coupled receptors. Arrestin binding prevents further G protein activation and often redirects signaling to other pathways. The comparison of the high-resolution crystal structures of arrestin2, visual arrestin, and rhodopsin as well as earlier mutagenesis and peptide inhibition data collectively suggest that the elements on the concave sides of both arrestin domains most likely participate in receptor binding directly, thereby dictating its receptor preference. Using comparative binding of visual arrestin/arrestin2 chimeras to the preferred target of visual arrestin, light-activated phosphorylated rhodopsin (PRh*), and to the arrestin2 target, phosphorylated activated m2 muscarinic receptor (P-m2 mAChR*), we identified the elements that determine the receptor specificity of arrestins. We found that residues 49-90 (beta-strands V and VI and adjacent loops in the N-domain) and 237-268 (beta-strands XV and XVI in the C-domain) in visual arrestin and homologous regions in arrestin2 are largely responsible for their receptor preference. Only 35 amino acids (22 of which are nonconservative substitutions) in the two elements are different. Simultaneous exchange of both elements between visual arrestin and arrestin2 fully reverses their receptor specificity, demonstrating that these two elements in the two domains of arrestin are necessary and sufficient to determine their preferred receptor targets.

摘要

抑制蛋白选择性地结合其同源G蛋白偶联受体的磷酸化活化形式。抑制蛋白的结合可防止G蛋白进一步活化,并常常将信号转导重定向至其他途径。抑制蛋白2、视紫红质抑制蛋白和视紫红质的高分辨率晶体结构比较,以及早期的诱变和肽抑制数据共同表明,两个抑制蛋白结构域凹面的元件很可能直接参与受体结合,从而决定其受体偏好性。利用视紫红质抑制蛋白/抑制蛋白2嵌合体与视紫红质抑制蛋白的首选靶标——光活化磷酸化视紫红质(PRh*)以及抑制蛋白2靶标——磷酸化活化M2型毒蕈碱受体(P-m2 mAChR*)的比较结合,我们确定了决定抑制蛋白受体特异性的元件。我们发现,视紫红质抑制蛋白中的49-90位残基(N结构域中的β链V和VI以及相邻环)和237-268位残基(C结构域中的β链XV和XVI)以及抑制蛋白2中的同源区域在很大程度上决定了它们的受体偏好性。这两个元件中只有35个氨基酸不同(其中22个是非保守取代)。视紫红质抑制蛋白和抑制蛋白2之间这两个元件的同时交换完全逆转了它们的受体特异性,表明抑制蛋白两个结构域中的这两个元件对于确定其首选受体靶标是必要且充分的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验